Pancreatic Cancer Research

ResearcherLiaoning Provincial People's HospitalNo recent work listed

Qi Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9193-2959; OpenAlex author ID A5103256430. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2013: 4 papers · 2014: 4 papers · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers

Papers 13

  1. Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein. Last author DOI 10.18632/oncotarget.28157↗
  2. Down-regulation of MSMO1 promotes the development and progression of pancreatic cancer. Co-author DOI 10.7150/jca.73112↗
  3. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. Co-author DOI 10.1111/jcmm.15676↗
  4. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein. Last author DOI 10.18632/oncotarget.8736↗
  5. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1016/j.surg.2015.03.016↗
  6. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer. Co-author DOI 10.1002/jcp.24519↗
  7. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer. Co-author DOI 10.1111/his.12273↗
  8. [The role of Gli1 in the invasion and migration of pancreatic cancer cells]. Last author PMID 25262609↗
  9. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer]. Co-author PMID 25410780↗
  10. Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer. Last author DOI 10.1002/jso.23282↗
  11. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer. Co-author DOI 10.1007/s00441-013-1679-6↗
  12. [Clinicopathological significance of the expression of calreticulin in human pancreatic cancer]. Last author PMID 23578430↗
  13. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer]. Last author PMID 24433772↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiwei Sheng · 13 shared papers, 2013–2022 · strength 0.99
  2. Ming Dong · 9 shared papers, 2013–2022 · strength 0.80
  3. Qingfeng Liu · 7 shared papers, 2013–2022 · strength 0.51
  4. Jianping Zhou · 8 shared papers, 2013–2014 · strength 0.37
  5. Rongxian Cao · 2 shared papers, 2020–2022 · strength 0.29
  6. Feng Li · 4 shared papers, 2013–2015 · strength 0.19
  7. Guosen Wang · 1 shared paper, 2020 · strength 0.11
  8. Chao Jia · 1 shared paper, 2020 · strength 0.11
  9. Lei Zhou · 1 shared paper, 2020 · strength 0.11
  10. Qingfeng Liu · 2 shared papers, 2014 · strength 0.09
  11. Xin Li · 2 shared papers, 2013 · strength 0.09
  12. Feng Li · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.